Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Is The Single-Cell Omics Market Expected To Grow In Terms Of Size?

The size of the single-cell omics market has seen significant expansions recently. The projections show an increase from $2.08 billion in 2024 to $2.39 billion in 2025, showcasing a compound annual growth rate (CAGR) of 14.9%. The previous growth in this specific market is connected to factors such as the advances in discovering cellular heterogeneity, the development of single-cell analysis tools, substantial progress in biomedical research, breakthroughs in immune system characterization, and the inception of precision medicine.

The size of the single-cell omics market is predicted to experience a swift expansion in the upcoming years, escalating to a figure of $4.45 billion in 2029 with a compound annual growth rate (CAGR) of 16.8%. The surge throughout the forecast period is credited to factors such as its clinical application and diagnostics, pairing with multi-omics methodologies, usage in regenerative medicine, the process of drug creation and discovery, as well as cellular treatments and immune therapies. Anticipated trends within this duration encompass in vivo single-cell exploration, application of single-cell omics in the study of infectious diseases, microfluidics integrated with single-cell sorting, amalgamation of single-cell multi-omics, and geographical single-cell profiling.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Which Growth Drivers Are Shaping The Single-Cell Omics Market Outlook?

The increase in cancer cases is predicted to spur the expansion of the single-cell omics market. Cancer encompasses a range of diseases that can occur almost anywhere in the body when rogue cells grow recklessly, overstep their normal limits, and either metastasize to other organs or invade adjacent body parts. The detection of cancer biomarkers for diagnosis and prognosis prediction, as well as the identification of new therapeutic targets in pre-established clinical groups, greatly benefits from single-cell omics data. For example, the National Institutes of Health, a government agency based in the United States, stated in May 2024 that as of January 2022, nearly 18.1 million people in the United States were living as cancer survivors. This figure is projected to increase to 22.5 million by 2032. Consequently, the rising incidence of cancer is contributing to the growth of the single-cell omics market.

How Is The Global Single-Cell Omics Market Broken Down By Segment?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

Which Trends Are Likely To Redefine Growth Paths In The Single-Cell Omics Market?

One emerging trend that’s gaining traction in the single-cell omics market is product innovation. To maintain their market position, leading businesses in the single-cell omics sector are focusing on the creation of innovative products. Take for example Deepcell, an American software company specializing in single-cell dimensional morphology analysis, which in May 2023, introduced the REM-I Platform. This scalable single-cell imaging platform combines high-dimensional analysis and cell sorting, opening up new realms of exploration in various fields such as cancer biology, developmental biology, gene therapy, stem cell biology, and functional screening among others. Moreover, it provides insights into cell biology that were previously out of reach.

Who Are The Most Influential Companies In The Single-Cell Omics Market?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Single-Cell Omics Market?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model